A key challenge in implementing the NDAA reform is doing so without obstructing the military's ability to maintain a "ready medical force and medically ready force." To maintain the military's ability, the DHA is utilizing recent technological advancements lifesaving innovations in an effort to modernize medical forces and facilities. In particular, the Biological Technologies Office within the Defense Advanced Research Projects Agency (DARPA) is currently researching biological technologies that will provide new tools for countering threats against our soldiers and country. This article explores what innovation is taking place with insight from Dr. Brad Ringeisen, Deputy Director of the Biological Technologies Office (BTO) at DARPA, who believes there is an urgent need to provide medical tools and technologies for military readiness.
The 2017 National Defense Authorization Act (NDAA) called for the major transformation of military healthcare and has consolidated primary responsibilities from the military departments to the Defense Health Agency (DHA). DHA is now aiming to modernize the medical forces and facilities by utilizing technological advancements and lifesaving innovation. This infographic includes the top largest proposed contracting opportunities from DHA with upcoming procurement plans. Prior to the upcoming Military Healthcare Summit this April in Washington D.C., we have outlined the top ten DHA contracting opportunities from largest to smallest anticipated value.